Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sodium Dichloroisocyanurate Dihydrate
2. 51580-86-0
3. Dichloroisocyanuric Acid Sodium Salt Dihydrate
4. Troclosene Sodium Dihydrate
5. Troclosene Sodium
6. Sodium;1,5-dichloro-4,6-dioxo-1,3,5-triazin-2-olate;dihydrate
7. Dsstox_cid_9761
8. Dsstox_rid_78820
9. Dsstox_gsid_29761
10. 8027syq9x3
11. Cas-51580-86-0
12. Ec 220-767-7
13. Unii-8027syq9x3
14. 1,3,5-triazine-2,4,6-(1h,3h,5h)-trione,1,3-dichloro-,sodiumsalt,dihydrate
15. Mfcd00149404
16. 1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1,3-dichloro-, Sodium Salt,dihydrate
17. 1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1,3-dichloro-, Sodium Salt, Dihydrate
18. Chembl3183152
19. Tox21_201922
20. Tox21_303426
21. Sodium Dichloroisocyanurate, Dihydrate
22. Ncgc00257415-01
23. Ncgc00259471-01
24. As-83573
25. Sodium Dichlorodi-isocyanurate, Dihydrate
26. Dichloroisocyanuric Acid Sodium Salt Dihydrate, Nadcc
27. Q27269102
28. Sodium Dichloroisocyanurate Dihydrate, >=98.0% (at)
29. Sodium 1,5-dichloro-4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazin-2-olate Dihydrate
| Molecular Weight | 255.97 g/mol |
|---|---|
| Molecular Formula | C3H4Cl2N3NaO5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 0 |
| Exact Mass | 254.9425699 g/mol |
| Monoisotopic Mass | 254.9425699 g/mol |
| Topological Polar Surface Area | 78 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 257 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
A Sodium Dichloroisocyanurate Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Dichloroisocyanurate Dihydrate, including repackagers and relabelers. The FDA regulates Sodium Dichloroisocyanurate Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Dichloroisocyanurate Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Dichloroisocyanurate Dihydrate supplier is an individual or a company that provides Sodium Dichloroisocyanurate Dihydrate active pharmaceutical ingredient (API) or Sodium Dichloroisocyanurate Dihydrate finished formulations upon request. The Sodium Dichloroisocyanurate Dihydrate suppliers may include Sodium Dichloroisocyanurate Dihydrate API manufacturers, exporters, distributors and traders.
Sodium Dichloroisocyanurate Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Dichloroisocyanurate Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Dichloroisocyanurate Dihydrate GMP manufacturer or Sodium Dichloroisocyanurate Dihydrate GMP API supplier for your needs.
A Sodium Dichloroisocyanurate Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Sodium Dichloroisocyanurate Dihydrate's compliance with Sodium Dichloroisocyanurate Dihydrate specifications and serves as a tool for batch-level quality control.
Sodium Dichloroisocyanurate Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Dichloroisocyanurate Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Dichloroisocyanurate Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Dichloroisocyanurate Dihydrate EP), Sodium Dichloroisocyanurate Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Dichloroisocyanurate Dihydrate USP).
LOOKING FOR A SUPPLIER?
